Articles dans des revues avec comité de lecture (154)
11.
Inampudi, C., Silverman, D., Simon, M. M., Leary, P. P., Sharma, K., Houston, B. B., Vachiery, J.-L., Haddad, F., & Tedford, R. R. (2021). Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction. Chest, 160(6), 2232-2246. doi:10.1016/j.chest.2021.08.03912.
Lambert, M., Mendes-Ferreira, P., Ghigna, M. R., Leribeuz, H., Adão, R., Boet, A., Capuano, V., Rucker-Martin, C., Brás-Silva, C., Quarck, R., Domergue, V., Vachiery, J.-L., Humbert, M., Perros, F., Montani, D., & Antigny, F. (2021). Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload. Cardiovascular Research, 117(12), 2474-2488. doi:10.1093/cvr/cvab01613.
Baratto, C., Caravita, S., Battista Perego, G., Badano, L., Vachiery, J.-L., & Parati, G. (2021). Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader. Circulation. Heart Failure, 281-283. doi:10.1161/CIRCHEARTFAILURE.120.00755414.
Chomette, L., Caravita, S., Dewachter, C., Abramowicz, M., Vachiery, J.-L., & Bondue, A. (2021). Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report. Pulmonary circulation, 11(1), PMID: 33738094. doi:10.1177/204589402199657115.
Hoeper, M. M., Gomez Sanchez, M. A., Humbert, M., Pittrow, D., Simonneau, G., Gall, H., Grünig, E., Klose, H., Halank, M., Langleben, D., Snijder, R. R., Escribano Subias, P., Mielniczuk, L., Lange, T. J., Vachiery, J.-L., Wirtz, H., Helmersen, D. D., Tsangaris, I., Barberà, J. A., Pepke-Zaba, J., Boonstra, A., Rosenkranz, S., Ulrich, S., Steringer-Mascherbauer, R., Delcroix, M., Jansa, P., Šimková, I., Giannakoulas, G., Klotsche, J., Williams, E., Meier, C., & Ghofrani, H. A. (2021). Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry. Respiratory medicine, 177, 106241. doi:10.1016/j.rmed.2020.10624116.
Unger, P., Paesmans, M., Vachiery, J.-L., Rietz, M., Amzulescu, M., & David-Cojocariu, A. (2021). Right ventricular longitudinal fractional shortening: a substitute to right ventricular free wall longitudinal strain? Heart and vessels. doi:10.1007/s00380-021-01928-617.
Baratto, C., Caravita, S., Soranna, D., Faini, A., Dewachter, C., Zambon, A., Perego, G. B., Bondue, A., Senni, M., Badano, L., Parati, G., & Vachiery, J.-L. (2021). Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction. Circulation. Heart Failure, 564-575. doi:10.1161/CIRCHEARTFAILURE.120.00755518.
Colin, G. G., Verlynde, G., Pouleur, A.-C., Gerber, B., Beauloye, C., Kefer, J., Coche, E., Vachiery, J.-L., Gevenois, P.-A., & Ghaye, B. (2020). Pulmonary hypertension due to left heart disease: diagnostic value of pulmonary artery distensibility. European radiology, 30(11), 6204-6212. doi:10.1007/s00330-020-06959-720.
Rothman, A. A., Vachiery, J.-L., Howard, L., Mikhail, G. G., Lang, I., Jonas, M., Kiely, D. G., Shav, D., Shabtay, O., Avriel, A., Lewis, G. D., Rosenzweig, E. E., Kirtane, A. J., Kim, N. H., Mahmud, E., McLaughlain, V. V., Chetcuti, S., Leon, M. M., Ben-Yehuda, O., & Rubin, L. (2020). Intravascular Ultrasound Pulmonary Artery Denervation to Treat Pulmonary Arterial Hypertension (TROPHY1): Multicenter, Early Feasibility Study. J A C C: Cardiovascular Interventions, 13(8), 989-999. doi:10.1016/j.jcin.2019.12.02721.
McLaughlin, V., Vachiery, J.-L., Oudiz, R. J., Rosenkranz, S., Galie, N., Barbera, J. A., Frost, A., Ghofrani, H. A., Peacock, A., Simonneau, G., Rubin, L., Blair, C., Langley, J., & Hoeper, M. M. (2019). Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial. The Journal of heart and lung transplantation, 38(12), 1286-1295. doi:10.1016/j.healun.2019.09.010